Effect of Heme Oxygenase-1 on Renal Function in Rats with Liver Cirrhosis

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2011 Jan 22

PMID 21253390

Citations 11

Authors

Shi-Bin Guo

Zhi-Jun Duan

Qing Li

Xiao-Yu Sun

Affiliations

Soon will be listed here.

Abstract

Aim: To investigate the role of heme oxygenase-1 (HO-1) in pathogenesis of experimental hepatorenal syndrome (HRS).

Methods: Rats were divided into liver cirrhotic group, zinc protoporphyrin IX (ZnPP) treatment group, cobalt protoporphyrin (CoPP) treatment group and sham group. Biliary cirrhosis was established by bile duct ligation in the first three groups. Rats in the ZnPP and CoPP treatment groups received intraperitoneal injection of ZnPP and CoPP, respectively, 24 h before sample collection. Expression of HO-1 mRNA in kidney was detected by reverse-transcription polymerase chain reaction, while protein expression was determined by immunohistochemical analysis. Hematoxylin and eosin staining was performed to observe liver cirrhosis and renal structure. Renal artery blood flow, mean arterial pressure and portal vein pressure, 24 h total urinary volume, serum and urine sodium concentrations, and creatinine clearance rate (Ccr) were also measured.

Results: The HO-1 mRNA and protein expression levels in kidney, 24 h total urinary volume, renal artery blood flow, serum and urine sodium concentration and Ccr were lower in cirrhotic group than in sham group (P < 0.05). However, they were significantly lower in ZnPP treatment group than in cirrhotic group and significantly higher in CoPP treatment group than in cirrhotic group (P < 0.05).

Conclusion: Low HO-1 expression level in kidney is an important factor for experimental HRS.

Citing Articles

Protective effect of long-chain polyunsaturated fatty acids on hepatorenal syndrome in rats.

Duailibe J, Viau C, Saffi J, Fernandes S, Porawski M World J Nephrol. 2024; 13(3):95627.

PMID: 39351184 PMC: 11439093. DOI: 10.5527/wjn.v13.i3.95627.

Overexpression of P-glycoprotein, MRP2, and CYP3A4 impairs intestinal absorption of octreotide in rats with portal hypertension.

Sun X, Tang S, Hou B, Duan Z, Liu Z, Li Y BMC Gastroenterol. 2021; 21(1):2.

PMID: 33407159 PMC: 7789354. DOI: 10.1186/s12876-020-01532-4.

Protective Effects of the Third Generation Vasodilatory Βeta - Blocker Nebivolol against D-Galactosamine - Induced Hepatorenal Syndrome in Rats.

Atwa A, Hegazy R, Mohsen R, Yassin N, Kenawy S Open Access Maced J Med Sci. 2018; 5(7):880-892.

PMID: 29362613 PMC: 5771289. DOI: 10.3889/oamjms.2017.173.

Inhibition of P-glycoprotein, multidrug resistance-associated protein 2 and cytochrome P450 3A4 improves the oral absorption of octreotide in rats with portal hypertension.

Sun X, Duan Z, Liu Z, Tang S, Li Y, He S Exp Ther Med. 2017; 12(6):3716-3722.

PMID: 28105103 PMC: 5228395. DOI: 10.3892/etm.2016.3808.

Bile Nephropathy in Flucloxacillin-Induced Cholestatic Liver Dysfunction.

Alnasrallah B, Collins J, Zwi L Case Rep Nephrol. 2016; 2016:4162674.

PMID: 27006842 PMC: 4783551. DOI: 10.1155/2016/4162674.

References

Wadei H, Mai M, Ahsan N, Gonwa T . Hepatorenal syndrome: pathophysiology and management. Clin J Am Soc Nephrol. 2007; 1(5):1066-79. DOI: 10.2215/CJN.01340406. View

Cardenas A . Hepatorenal syndrome: a dreaded complication of end-stage liver disease. Am J Gastroenterol. 2005; 100(2):460-7. DOI: 10.1111/j.1572-0241.2005.40952.x. View

Verma A, Hirsch D, Glatt C, Ronnett G, Snyder S . Carbon monoxide: a putative neural messenger. Science. 1993; 259(5093):381-4. DOI: 10.1126/science.7678352. View

Naik J, ODonaughy T, Walker B . Endogenous carbon monoxide is an endothelial-derived vasodilator factor in the mesenteric circulation. Am J Physiol Heart Circ Physiol. 2002; 284(3):H838-45. DOI: 10.1152/ajpheart.00747.2002. View

Miyazono M, Garat C, Morris Jr K, Carter E . Decreased renal heme oxygenase-1 expression contributes to decreased renal function during cirrhosis. Am J Physiol Renal Physiol. 2002; 283(5):F1123-31. DOI: 10.1152/ajprenal.00363.2001. View

Maines M . The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997; 37:517-54. DOI: 10.1146/annurev.pharmtox.37.1.517. View

Turkay C, Yonem O, Arikan O, Baskin E . Nitric oxide and renal functions in liver cirrhosis. Turk J Gastroenterol. 2004; 15(2):73-6. View

Fallon M, Abrams G, McGrath J, Hou Z, Luo B . Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome. Am J Physiol. 1997; 272(4 Pt 1):G779-84. DOI: 10.1152/ajpgi.1997.272.4.G779. View

Kozma F, Johnson R, Nasjletti A . Role of carbon monoxide in heme-induced vasodilation. Eur J Pharmacol. 1997; 323(2-3):R1-2. DOI: 10.1016/s0014-2999(97)00145-3. View

10.

Wei C, Lee K, Khoo H, Hon W . Expression of haem oxygenase in cirrhotic rat liver. J Pathol. 2003; 199(3):324-34. DOI: 10.1002/path.1284. View

11.

Islas-Carbajal M, Covarrubias A, Grijalva G, Alvarez-Rodriguez A, Armendariz-Borunda J, Rincon-Sanchez A . Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats. Liver Int. 2005; 25(1):131-40. DOI: 10.1111/j.1478-3231.2005.01018.x. View

12.

Christodoulides N, Durante W, Kroll M, Schafer A . Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation. 1995; 91(9):2306-9. DOI: 10.1161/01.cir.91.9.2306. View

13.

Drummond G . Control of heme metabolism by synthetic metalloporphyrins. Ann N Y Acad Sci. 1987; 514:87-95. DOI: 10.1111/j.1749-6632.1987.tb48764.x. View

14.

Kozma F, Johnson R, Zhang F, Yu C, Tong X, Nasjletti A . Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels. Am J Physiol. 1999; 276(4):R1087-94. DOI: 10.1152/ajpregu.1999.276.4.R1087. View

15.

Meltzer J, Brentjens T . Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies. Curr Opin Anaesthesiol. 2010; 23(2):139-44. DOI: 10.1097/ACO.0b013e32833724a8. View

16.

Da Silva J, Zand B, Yang L, Sabaawy H, Lianos E, Abraham N . Heme oxygenase isoform-specific expression and distribution in the rat kidney. Kidney Int. 2001; 59(4):1448-57. DOI: 10.1046/j.1523-1755.2001.0590041448.x. View

17.

Leung N, Croatt A, Haggard J, Grande J, Nath K . Acute cholestatic liver disease protects against glycerol-induced acute renal failure in the rat. Kidney Int. 2001; 60(3):1047-57. DOI: 10.1046/j.1523-1755.2001.0600031047.x. View

18.

Amersi F, Buelow R, Kato H, Ke B, Coito A, Shen X . Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest. 1999; 104(11):1631-9. PMC: 409865. DOI: 10.1172/JCI7903. View

19.

Arroyo V, Fernandez J, Gines P . Pathogenesis and treatment of hepatorenal syndrome. Semin Liver Dis. 2008; 28(1):81-95. DOI: 10.1055/s-2008-1040323. View

20.

Bomzon A, Holt S, Moore K . Bile acids, oxidative stress, and renal function in biliary obstruction. Semin Nephrol. 1997; 17(6):549-62. View